PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRCT PROCEPT BioRobotics

Post-Market Trading 10-24 16:21:56 EDT

66.83

-0.49

-0.73%

盘后66.83

+0.000.00%

16:20 EDT

High70.33	Low66.78	Vol795.20K
Open67.37	D1 Closing67.32	Amplitude5.27%
Mkt Cap3.47B	Tradable Cap3.31B	Total Shares51.93M
T/O54.03M	T/O Rate1.60%	Tradable Shares49.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"PRCT","market":"US","secType":"STK","nameCN":"PROCEPT BioRobotics","latestPrice":66.83,"timestamp":1729800000000,"preClose":67.32,"halted":0,"volume":795198,"hourTrading":{"tag":"盘后","latestPrice":66.83,"preClose":66.83,"latestTime":"16:20 EDT","volume":2334,"amount":155981.22,"timestamp":1729801200543},"delay":0,"floatShares":49576334,"shares":51932262,"eps":-2.057657,"marketStatus":"Post-Market Trading","change":-0.49,"latestTime":"10-24 16:21:56 EDT","open":67.37,"high":70.33,"low":66.78,"amount":54028288.80162,"amplitude":0.052733,"askPrice":70.25,"askSize":69,"bidPrice":66.64,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-2.057657,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1729814400000},"marketStatusCode":4,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":67.32,"preHourTrading":{"tag":"盘前","latestPrice":67.31,"preClose":67.32,"latestTime":"08:28 EDT","volume":31,"amount":2060.1018999999997,"timestamp":1729772889078},"postHourTrading":{"tag":"盘后","latestPrice":66.83,"preClose":66.83,"latestTime":"16:20 EDT","volume":2334,"amount":155981.22,"timestamp":1729801200543},"volumeRatio":1.211311,"impliedVol":1.2623,"impliedVolPercentile":0.9802},"requestUrl":"/m/hq/s/PRCT/wiki","defaultTab":"wiki","newsList":[{"id":"2477656878","title":"Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2477656878","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477656878?lang=en_us&edition=fundamental","pubTime":"2024-10-24 22:01","pubTimestamp":1729778482,"startTime":"0","endTime":"0","summary":"The market expects Teleflex  to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on October 31, 2024, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This medical equipment maker is expected to post quarterly earnings of $3.38 per share in its upcoming report, which represents a year-over-year cha","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/HIalcDlt7JZPKSITVlxPuw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/HIalcDlt7JZPKSITVlxPuw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/earnings-preview-teleflex-tfx-q3-140122453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TFX","PRCT"],"gpt_icon":0},{"id":"2477670918","title":"PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2477670918","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477670918?lang=en_us&edition=fundamental","pubTime":"2024-10-21 22:00","pubTimestamp":1729519221,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics Corporation  is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on October 28, 2024, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This company is expected to post quarterly loss of $0.48 per share in its upcoming report, which represents a year-over-year change of +5.9%.Please note ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/CorpxfcSD3xaruoFanouDg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/CorpxfcSD3xaruoFanouDg--~B/aD00NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/procept-biorobotics-corporation-prct-expected-140021764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRCT"],"gpt_icon":0},{"id":"2474753986","title":"Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), PROCEPT BioRobotics (PRCT) and Travere Therapeutics (TVTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2474753986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474753986?lang=en_us&edition=fundamental","pubTime":"2024-10-10 10:50","pubTimestamp":1728528615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biohaven Ltd. (BHVN – Research Report), PROCEPT BioR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biohaven-ltd-bhvn-procept-biorobotics-prct-and-travere-therapeutics-tvtx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biohaven-ltd-bhvn-procept-biorobotics-prct-and-travere-therapeutics-tvtx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT","BK4137","LU1093756168.USD","BK4082","TVTX","LU1093756325.SGD","BK4139","LU2324357040.USD","HCSG","BHVN"],"gpt_icon":0},{"id":"2474209455","title":"PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2474209455","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474209455?lang=en_us&edition=fundamental","pubTime":"2024-10-10 04:04","pubTimestamp":1728504240,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., Oct.  09, 2024  (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/09/2960901/0/en/PROCEPT-BioRobotics-to-Report-Third-Quarter-2024-Financial-Results-on-October-28-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","PRCT","BK4082"],"gpt_icon":0},{"id":"2474402814","title":"PRCT Stock Rises on FDA's Nod to Initiate Study on Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2474402814","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474402814?lang=en_us&edition=fundamental","pubTime":"2024-10-09 00:42","pubTimestamp":1728405720,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics Corporation PRCT recently announced that it has received theFDA’s approval to commence a pivotal Investigational Device Exemption clinical trial comparing Aquablation therapy to radical prostatectomy. The study will evaluate the efficacy of Aquablation therapy for patients with prostate cancer.This approval marks a critical step in the company's objective to revolutionize treatment options for patients suffering from prostate cancer. The company also recently received Breakthrough Device Designation to investigate the use of Aquablation therapy for prostate cancer.Following the announcement, shares of the company moved north 4.9% in the after-market session on Monday.PRCT’s innovative solutions, particularly Aquablation therapy, have positioned the company as a major player in the medical robotics space. With this FDA approval, the company is expected to gain traction among investors looking for growth opportunities in the healthcare sector.Meanwhile, PRCT currently","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZcqDt7bCeBMLkGs_KJ1O8A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZcqDt7bCeBMLkGs_KJ1O8A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/228e67967b066e7a755ae3614be720e1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/prct-stock-rises-fdas-nod-164200364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INSP","BK4588","LU2265009873.SGD","IE0002141913.USD","LU2362541513.USD","IE0009355771.USD","LU2506952170.USD","LU0823416689.USD","LU2506952097.USD","LU2491049909.HKD","LU2362541273.HKD","LU0077335932.USD","IE00B2B36J28.USD","LU0011850046.USD","LU2491050071.SGD","LU1023059063.AUD","BK4504","IE00BFTCPJ56.SGD","LU1983299246.USD","TMDX","LU1153585028.USD","LU2324357040.USD","LU1057294990.SGD","LU1791710582.SGD","LU2506951958.HKD","BK4585","LU0353189763.USD","LU2065731478.USD","LU2491050154.USD","BSX","LU0238689110.USD","BK4082","LU0345769128.USD","LU2112291526.USD","LU1791710400.SGD","LU0114720955.EUR","LU0823417653.USD","PRCT","LU1291159041.SGD","LU0345769631.USD","LU2087625088.SGD","LU0187121727.USD","BK4167","LU1804176565.USD","LU0823417737.USD","LU2506951875.HKD","IE00B4R5TH58.HKD","BK4581","LU1718418525.SGD","LU0266013472.USD"],"gpt_icon":0},{"id":"2473479171","title":"PROCEPT BioRobotics Price Target Maintained With a $75.00/Share by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2473479171","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473479171?lang=en_us&edition=fundamental","pubTime":"2024-10-08 22:46","pubTimestamp":1728398760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 08, 2024 10:46 ET (14:46 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"gpt_icon":0},{"id":"2473425031","title":"TD Cowen Reaffirms Their Buy Rating on PROCEPT BioRobotics (PRCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2473425031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473425031?lang=en_us&edition=fundamental","pubTime":"2024-10-08 19:45","pubTimestamp":1728387924,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Josh Jennings maintained a Buy rating on PROCEPT BioRobotics (PRCT – Research Report) today and set a price target of $99.00. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-procept-biorobotics-prct?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-procept-biorobotics-prct?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","TD","PRCT"],"gpt_icon":0},{"id":"2473428476","title":"PROCEPT BioRobotics (PRCT) Receives a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2473428476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473428476?lang=en_us&edition=fundamental","pubTime":"2024-10-08 19:05","pubTimestamp":1728385527,"startTime":"0","endTime":"0","summary":"In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on PROCEPT BioRobotics (PRCT – Research Report). The com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/procept-biorobotics-prct-receives-a-buy-from-truist-financial-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/procept-biorobotics-prct-receives-a-buy-from-truist-financial-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT","LU2324357040.USD","BK4082"],"gpt_icon":0},{"id":"2473447240","title":"Piper Sandler Sticks to Its Buy Rating for PROCEPT BioRobotics (PRCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2473447240","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473447240?lang=en_us&edition=fundamental","pubTime":"2024-10-08 18:47","pubTimestamp":1728384466,"startTime":"0","endTime":"0","summary":"In a report released today,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-procept-biorobotics-prct?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-procept-biorobotics-prct?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT"],"gpt_icon":0},{"id":"2473436865","title":"Procept BioRobotics Gets FDA Approval to Start Study for Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2473436865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473436865?lang=en_us&edition=fundamental","pubTime":"2024-10-08 04:33","pubTimestamp":1728333231,"startTime":"0","endTime":"0","summary":"Procept BioRobotics  said Monday that it has received approval from the US Food and Drug Administration for an investigational device exemption clinical trial to compare Aquablation therapy with radical prostatectomy.The study will enroll up to 280 patients at up to 50 centers and follow them for 10 years, the company said. It recently received Breakthrough Device Designation to investigate the use of Aquablation therapy for prostate cancer.Price: 71.56, Change: +1.94, Percent Change: +2.79","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","PRCT","BK4082"],"gpt_icon":0},{"id":"2473433925","title":"Procept Biorobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2473433925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473433925?lang=en_us&edition=fundamental","pubTime":"2024-10-08 04:04","pubTimestamp":1728331440,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241007:nTUA9SG2RD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4082","PRCT"],"gpt_icon":0},{"id":"2473433145","title":"PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2473433145","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473433145?lang=en_us&edition=fundamental","pubTime":"2024-10-08 04:04","pubTimestamp":1728331440,"startTime":"0","endTime":"0","summary":"A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate Cancer Represents Potential Paradigm Shift in Ho","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/07/2959294/0/en/PROCEPT-BioRobotics-Received-U-S-FDA-Approval-to-Initiate-Pivotal-Randomized-Clinical-Study-for-Prostate-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IDE","LU2324357040.USD","PRCT"],"gpt_icon":0},{"id":"2473799189","title":"PROCEPT BioRobotics Corporation (PRCT) Advances Urology with AI-Integrated HYDROS Robotic System; Price Target Raised to $99","url":"https://stock-news.laohu8.com/highlight/detail?id=2473799189","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473799189?lang=en_us&edition=fundamental","pubTime":"2024-10-06 06:04","pubTimestamp":1728165863,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 20 Hidden Gem AI Stocks.In this article, we are going to take a look at where PROCEPT BioRobotics Corporation  stands against the other hidden gem AI stocks.The rise of artificial intelligence  businesses has loomed large over finance markets in the past few months, pushing investor attention away from other topics. This is because AI-enabled breakthroughs are creating new areas of focus for investors and disrupting major industries. Some of the major themes in this regard include AI-powered systems for environmental monitoring, ethical discussions surrounding the role of AI in healthcare, and the continued evolution of large language models. For example, tech giant Microsoft recently led the development of an AI system capable of predicting air pollution on a global scale. This system generates real-time, hyperlocal pollution forecasts, using data from satellites and ground sensors. The breakthrough could prove crucial for public health, especially i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DSPqMnmb8J1PAuz.iVje4w--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DSPqMnmb8J1PAuz.iVje4w--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/procept-biorobotics-corporation-prct-advances-220423308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRCT"],"gpt_icon":0},{"id":"2470521102","title":"Is Procept Biorobotics Corp. (PRCT) the Worst AI Stock to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2470521102","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470521102?lang=en_us&edition=fundamental","pubTime":"2024-09-25 21:01","pubTimestamp":1727269313,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Worst AI Stocks to Buy According to Reddit. In this article, we will look at where Procept Biorobotics Corp.  ranks among the worst AI stocks to buy.In the lead-up to the September rate cut decision, analysts had expressed a variety of opinions regarding the 50 basis-point cut, with some supporting and others opposing it. Some of them suggested that lower interest rates could create opportunities in small and mid-cap stocks, which may benefit from a more favorable borrowing environment.Michael Khouw, OpenInterest.PRO Chief Strategist, discussed that the stock market experienced a broadly lower performance recently, with the NASDAQ Composite suffering the most significant decline, down 0.5%. The S&P 500 also saw a decrease, giving up 24 points to close below 5,700, while the Dow Jones Industrial Average was down by 60 points at the time of reporting. Despite this overall downturn, the utility sector o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DSPqMnmb8J1PAuz.iVje4w--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DSPqMnmb8J1PAuz.iVje4w--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/procept-biorobotics-corp-prct-worst-130153411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["US7Y.BOND","PSQ","US10Y.BOND","US12M.BOND","US6M.BOND","LU2324357040.USD","PRCT","US3Y.BOND","US30Y.BOND","BK4082","NQmain","TQQQ","US912797HE00.BOND","US2Y.BOND","IDE","QID",".IXIC","BK4547","US5Y.BOND","US912797GW17.BOND","COMP","QLD","MNQmain","RDDT","BK4077","SQQQ"],"gpt_icon":1},{"id":"2469119187","title":"Procept Biorobotics Corporation (PRCT): Why Are Short Sellers Betting Against This Hospital Tech Innovator?","url":"https://stock-news.laohu8.com/highlight/detail?id=2469119187","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469119187?lang=en_us&edition=fundamental","pubTime":"2024-09-23 21:03","pubTimestamp":1727096629,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Worst Small Cap AI Stocks To Buy According to Short Sellers. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation  stands against other worst small cap AI stocks.Analysts have been anticipating interest rate cuts for a while now, with bets on either a 25- or a 50-basis point reduction. Concerns about potential economic instability and the impact of these cuts on net interest income for banks added complexity to the market outlook. However, the situation was sorted when the Fed cut interest rates by 50 basis points on September 18 this week, marking its first easing of monetary policy since the pandemic began.This reduction was prompted by growing concerns about the labor market’s health. Following this decision, the Fed’s benchmark rate now stands at a range of 4.75% to 5.0%.Right after the Fed’s announcement, Mark Avallone, president at Potomac Wealth Advisors, discussed his reaction to the Fed’s 50 basis-point rate c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DSPqMnmb8J1PAuz.iVje4w--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DSPqMnmb8J1PAuz.iVje4w--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/procept-biorobotics-corporation-prct-why-130349948.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QID","US30Y.BOND","US912797GW17.BOND","US912797HE00.BOND","NQmain","QLD","PRCT","US2Y.BOND","SQQQ","US10Y.BOND","US7Y.BOND","US3Y.BOND","BK4082","PSQ","US6M.BOND","LU2324357040.USD","MNQmain","TQQQ","US12M.BOND","US5Y.BOND",".IXIC"],"gpt_icon":1},{"id":"2468847150","title":"PROCEPT BioRobotics Currently Up Nine Consecutive Days, Longest Winning Streak Since September 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2468847150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468847150?lang=en_us&edition=fundamental","pubTime":"2024-09-17 00:13","pubTimestamp":1726503180,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics Corp.  is currently at $82.75, up $1.64 or 2.02%. --Would be highest close since Aug. 21, 2024, when it closed at $83.44. --Currently up nine consecutive days; up 10.25% over this period. --Longest winning streak since Sept. 7, 2023, when it rose for nine straight trading days. --Best nine day stretch since the nine days ending Sept. 3, 2024, when it rose 15.47%. --Down 0.83% from its all-time closing high of $83.44 on Aug. 21, 2024. --Up 150.38% from 52 weeks ago , when it closed at $33.05. --Up 232.46% from its 52-week closing low of $24.89 on Oct. 30, 2023. --Traded as high as $83.65; highest intraday level since Aug. 22, 2024, when it hit $85.77","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4082","PRCT"],"gpt_icon":0},{"id":"2467891443","title":"Buy Rating Affirmed for PROCEPT BioRobotics on Hydros Platform Launch and Positive Long-Term Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2467891443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467891443?lang=en_us&edition=fundamental","pubTime":"2024-09-16 16:15","pubTimestamp":1726474515,"startTime":"0","endTime":"0","summary":"In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on PROCEPT BioRobotics (PRCT – Research Report), with a price targe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-procept-biorobotics-on-hydros-platform-launch-and-positive-long-term-growth-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-procept-biorobotics-on-hydros-platform-launch-and-positive-long-term-growth-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT"],"gpt_icon":0},{"id":"2466131182","title":"Procept BioRobotics: New Hydros Aquablation System To Fuel Next Leg Of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2466131182","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466131182?lang=en_us&edition=fundamental","pubTime":"2024-09-12 11:07","pubTimestamp":1726110420,"startTime":"0","endTime":"0","summary":"Procept Biorobotics is a top performer in the medical device industry, offering relief for men with BPH.The company's minimally invasive procedure is experiencing rapid growth in both system sales and","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/113121982/image_113121982.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/113121982/image_113121982.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4720582-procept-biorobotics-new-hydros-aquablation-system-to-fuel-next-leg-of-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["PRCT","BK4082","LU2324357040.USD"],"gpt_icon":0},{"id":"2466232864","title":"Fidelity Select Health Care Portfolio Q2 2024 Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2466232864","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466232864?lang=en_us&edition=fundamental","pubTime":"2024-09-12 00:15","pubTimestamp":1726071300,"startTime":"0","endTime":"0","summary":"Click to enlarge  Market Review Health care stocks returned -1.28% in the second quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, behind the 4.28% gain of the broad-based S&P 500 index. The broader U.S. stock market","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1937215058/image_1937215058.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1937215058/image_1937215058.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4720488-fidelity-select-health-care-portfolio-q2-2024-review","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["GKOS","INSP","IVV","PODD","LU1430594728.SGD",".SPX","LU0417517546.SGD","LU2063271972.USD","OEX","LU0256863811.USD","LU2125909593.SGD","DHR","LU0234570918.USD","SDS","LU0048584097.USD","LU2242646821.SGD","PEN","BSX","TXG","LU2506952170.USD","REGN","SPXU","LU2125909247.SGD","LU0198837287.USD","GB00BDT5M118.USD","LU1923622614.USD","NVO","SPY","OEF","BMY","IE00BJLML261.HKD","LU1878469433.USD","SLCT","VOO","UNH","LU0320765992.SGD","ESmain","LU0234572021.USD","PRCT","JNJ","LLY","IE000M9KFDE8.USD","EXAS","LU0985481810.HKD","SSO","BK4154","ALNY","SH","CVS"],"gpt_icon":1},{"id":"2464880349","title":"PROCEPT BioRobotics Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2464880349","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464880349?lang=en_us&edition=fundamental","pubTime":"2024-09-03 20:35","pubTimestamp":1725366900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 03, 2024 08:35 ET (12:35 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.procept-biorobotics.com","stockEarnings":[{"period":"1week","weight":-0.0709},{"period":"1month","weight":-0.1609},{"period":"3month","weight":0.0453},{"period":"6month","weight":0.2989},{"period":"1year","weight":1.4444},{"period":"ytd","weight":0.6063}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":0.0146},{"period":"3month","weight":0.0735},{"period":"6month","weight":0.1372},{"period":"1year","weight":0.3644},{"period":"ytd","weight":0.216}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.072581},{"month":2,"riseRate":0.666667,"avgChangeRate":0.11813},{"month":3,"riseRate":0.666667,"avgChangeRate":0.060469},{"month":4,"riseRate":1,"avgChangeRate":0.052799},{"month":5,"riseRate":1,"avgChangeRate":0.151369},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.062512},{"month":7,"riseRate":0.666667,"avgChangeRate":0.060791},{"month":8,"riseRate":0.666667,"avgChangeRate":0.098323},{"month":9,"riseRate":0.666667,"avgChangeRate":0.000091},{"month":10,"riseRate":0.5,"avgChangeRate":-0.031858},{"month":11,"riseRate":0.333333,"avgChangeRate":0.030556},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.044888}],"exchange":"NASDAQ","name":"PROCEPT BioRobotics","nameEN":"PROCEPT BioRobotics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PROCEPT BioRobotics,PRCT,PROCEPT BioRobotics股票,PROCEPT BioRobotics股票老虎,PROCEPT BioRobotics股票老虎国际,PROCEPT BioRobotics行情,PROCEPT BioRobotics股票行情,PROCEPT BioRobotics股价,PROCEPT BioRobotics股市,PROCEPT BioRobotics股票价格,PROCEPT BioRobotics股票交易,PROCEPT BioRobotics股票购买,PROCEPT BioRobotics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction